Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

mHealth Developer Works Around Traditional Reimbursement Barriers

Executive Summary

Glooko says it has found more success by pitching its diabetes management app to self-insured employers and to payers as a tool they can implement to reduce spending, rather than by pursuing reimbursement the traditional way. It's one model for the digital-health sector in the current health-care environment.

You may also be interested in...



Market Intel: Digital Tech At The Heart Of Cardiology Innovation

Digital health technologies from smartphone applications, wearables, digital weight scales and telehealth are rapidly changing the landscape of cardiac care, offering new tools for engaging cardiology patients and enhancing cardiologists' workflows. There is a lot of hype, but also some real promise. Here's a look at what's happening and some expert insights on the benefits and challenges these new innovations represent, as well as market projections. Digital health was a major topic of discussion by cardiologists and entrepreneurs during this year's Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. This is the second in a series of articles on the future of cardiovascular technology, spotlighting discussion and presentations from TCT.

New Mega Health-Care Trio Offers Opportunity For Digital Sector

A new independent health-care company created by Amazon, Berkshire Hathaway and JPMorgan will put an emphasis on using technology to "simplify" health care. That is music to the ears of digital-health firms.

Bulked-Up Glooko To Launch 'Unified' Diabetes Offering Next Year

Glooko and Diasend, two specialists in software solutions for diabetes management, have merged. With a new cash injection of $8m from venture investors, the combined company expects to launch its first product that brings together each entity's know-how next year.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel